Fresenius Medical Care Canada
John Hunter is an experienced executive in the healthcare industry, currently serving as a Board Member at Medtech Canada since 2022 and as Managing Director at Fresenius Medical Care Canada since January 2019. Prior to these roles, John held the position of Global Marketing Director for Rybelsus at Novo Nordisk from July 2015 to January 2019. John Hunter's educational background includes a Master of Laws (LLM) from the University of Toronto, studies in Statistics at Harvard University, a degree in Healthcare Value from the University of Oxford, a Bachelor of Commerce (HBA) from the University of Windsor, and an MBA from Wilfrid Laurier University.
This person is not in any teams
Fresenius Medical Care Canada
Fresenius Medical Care is the world’s leading provider of products and services for people with chronic kidney failure. We provide a complete solution for patients with chronic kidney failure and their caregivers, from research and development to manufacturing our dialysis products to providing complete therapy options within our own clinics. Fresenius Medical Care provides dialysis services in over 120 countries, including over 3,900 dialysis clinics and 42 production sites worldwide. Fresenius Medical Care Canada has cared for patients undergoing dialysis for over 25 years. We understand the impact that chronic kidney failure has on people's lives and we are committed to providing outstanding patient care that goes beyond innovative dialysis products and therapies. We care about each patient’s individual situation, whether they want to perform dialysis in their familiar surroundings at home, undergo dialysis at the hospital, or receive dialysis in one of our clinics. Our vision is to be the undisputed leader and trusted partner in renal therapies in Canada, and this vision is reflected in our key values: collaborative, proactive, reliable, excellent.